HEINEKEN Holding NV
Heineken Holding N.V. Annual General Meeting adopts all proposals
Heineken Holding N.V. Annual General Meeting adopts all proposals
Heineken Holding N.V. Annual General Meeting adopts all proposals
Amsterdam, 17 April 2025 - Heineken Holding N.V. announced today that its Annual General Meeting of Shareholders (AGM) has adopted all proposals on the agenda of the AGM. The most important resolutions and announcements are listed below.
Dividend
The Board of Directors announced the distribution of a dividend for the year 2024 of EUR 1.86 per share. As an interim dividend of EUR 0.69 was paid on 8 August 2024, the final dividend of EUR 1.17 per share will be made payable on 2 May 2025. Heineken Holding N.V. shares will be quoted ex-dividend on 23 April 2025.
Reappointment of Mr A.A.C. de Carvalho as non-executive member of the Board of Directors
The AGM reappointed Mr A.A.C. de Carvalho as non-executive member of the Board of Directors for a four-year term, until the end of the AGM to be held in 2029.
Appointment of Mr R.J.M.S. Huët as non-executive member of the Board of Directors
The AGM appointed Mr R.J.M.S. Huët as non-executive member of the Board of Directors for a four-year term, until the end of the AGM to be held in 2029.
Appointment of External Auditor
The AGM reappointed KPMG Accountants N.V. (KPMG) as external auditor for financial reporting for the financial year 2026, and appointed KPMG as external auditor for sustainability reporting for the financial years 2025 and 2026.
The voting results per agenda item of the AGM of Heineken Holding N.V. of 17 April 2025 can be found on the website www.heinekenholding.com as of close of business on 18 April 2025.
-ENDS-
Media Heineken Holding N.V.
Kees Jongsma
Tel: +31 6 54 79 82 53
Email: cjongsma@spj.nl
Press enquiries
Christiaan Prins / Marlie Paauw
E-mail: pressoffice@heineken.com
Tel: +31-20-5239-355
Investor and analyst enquiries
Tristan van Strien / Lennart Scholtus
E-mail: investors@heineken.com
Tel: +31-20-5239-590
Editorial information:
Heineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company.
HEINEKEN is the world's most international brewer. It is the leading developer and marketer of premium and non-alcoholic beer and cider brands. Led by the Heineken® brand, the Group has a portfolio of more than 340 international, regional, local and specialty beers and ciders. With HEINEKEN’s over 85,000 employees, HEINEKEN brews the joy of true togetherness to inspire a better world. HEINEKEN's dream is to shape the future of beer and beyond to win the hearts of consumers. HEINEKEN is committed to innovation, long-term brand investment, disciplined sales execution and focused cost management. Through "Brew a Better World", sustainability is embedded in the business. HEINEKEN has a well-balanced geographic footprint with leadership positions in both developed and developing markets. HEINEKEN operates breweries, malteries, cider plants and other production facilities in more than 70 countries. Most recent information is available on the websites: www.heinekenholding.com and www.theHEINEKENcompany.com and follow HEINEKEN on LinkedIn and Instagram.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
798 Art District26.4.2025 14:44:55 CEST | Press release
798 Art District and Beijing International Film Festival Jointly Launch “Art Lights the Screen” – A Cultural Feast of Film and Art
Atlantic Petroleum P/F26.4.2025 14:32:40 CEST | Press release
Summons for the Annual General Meeting of P/F Atlantic Petroleum
Financière de Tubize SA26.4.2025 08:00:00 CEST | Press release
Financière de Tubize - Dividend approval
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom